KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iqvia Holdings (IQV) Cash & Equivalents: 2011-2025

Historic Cash & Equivalents for Iqvia Holdings (IQV) over the last 14 years, with Sep 2025 value amounting to $1.8 billion.

  • Iqvia Holdings' Cash & Equivalents rose 15.39% to $1.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 billion, marking a year-over-year increase of 15.39%. This contributed to the annual value of $1.7 billion for FY2024, which is 23.69% up from last year.
  • Per Iqvia Holdings' latest filing, its Cash & Equivalents stood at $1.8 billion for Q3 2025, which was down 11.03% from $2.0 billion recorded in Q2 2025.
  • In the past 5 years, Iqvia Holdings' Cash & Equivalents registered a high of $2.3 billion during Q1 2021, and its lowest value of $1.2 billion during Q4 2022.
  • For the 3-year period, Iqvia Holdings' Cash & Equivalents averaged around $1.6 billion, with its median value being $1.5 billion (2024).
  • As far as peak fluctuations go, Iqvia Holdings' Cash & Equivalents spiked by 148.65% in 2021, and later tumbled by 39.83% in 2022.
  • Over the past 5 years, Iqvia Holdings' Cash & Equivalents (Quarterly) stood at $1.4 billion in 2021, then declined by 10.98% to $1.2 billion in 2022, then increased by 13.16% to $1.4 billion in 2023, then grew by 23.69% to $1.7 billion in 2024, then rose by 15.39% to $1.8 billion in 2025.
  • Its Cash & Equivalents stands at $1.8 billion for Q3 2025, versus $2.0 billion for Q2 2025 and $1.7 billion for Q1 2025.